✦ LIBER ✦

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

✍ Scribed by Igor S. Lukashevich; Ricardo Carrion Jr.; Maria S. Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E. Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson

Book ID: 116960814
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 943 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.07.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of ML29 Reassortant

Safety and Efficacy of ML29 Reassortant Lassa Fever Vaccine in Non-Human Primates

✍ I.S. Lukashevich; J.C. Zapata; M. Goicochea; R. Carrion Jr.; J.L. Patterson; K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effects of the potency and composition o

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants

✍ Timo Vesikari; H Fred Clark; Paul A. Offit; Michael J. Dallas; Daniel J. DiStefa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Evaluation in non-human primates of the

Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus

✍ Robert A. Olmsted; Robert M.L. Buller; Peter L. Collins; William T. London; Judy 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Recombinant, chimaeric live, attenuated

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

✍ T.P Monath; K Soike; I Levenbook; Z.-X Zhang; J Arroyo; S Delagrave; G Myers; A. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB